![](/images/graphics-bg.png)
Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer
Joint Authors
Bhattacharyya, Tapesh
Babu, Geethu
Kainickal, Cessal Thommachan
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-10-01
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Nasopharyngeal carcinoma is highly radio- and chemosensitive tumor with its unique clinical and biological behavior.
Treatment of stage I disease is radical radiotherapy alone.
For stage II disease treatment is radiotherapy with or without chemotherapy.
The standard of care for locally advanced nasopharyngeal cancer (stages III-IVB) is concurrent chemoradiation.
Optimum timing and sequence of chemotherapy are not yet well-defined.
The role of adjuvant and induction chemotherapy is debatable.
Here we are going to highlight the role of chemotherapy in nasopharyngeal carcinoma, its benefit, and controversies regarding timing and sequences.
American Psychological Association (APA)
Bhattacharyya, Tapesh& Babu, Geethu& Kainickal, Cessal Thommachan. 2018. Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer. Journal of Oncology،Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1195780
Modern Language Association (MLA)
Bhattacharyya, Tapesh…[et al.]. Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer. Journal of Oncology No. 2018 (2018), pp.1-7.
https://search.emarefa.net/detail/BIM-1195780
American Medical Association (AMA)
Bhattacharyya, Tapesh& Babu, Geethu& Kainickal, Cessal Thommachan. Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer. Journal of Oncology. 2018. Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1195780
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1195780